Product Information

POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0936 per EA under NDC 70010014701. Its NADAC has been published 245 times since Dec 15, 2021.

FDA first approved this application on Feb 16, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 8 MEQ CAPSULE

Potassium Chloride
$0.0936per EA

Strength

600 mg/1

NDC

70010014701

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA214686

FDA Approved

2/16/2021

TE Code

AB

On Market Since

3/1/2021

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 245 times since Dec 15, 2021, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0936 per EA
All-time high$0.2404 (Dec 15, 2021)
All-time low$0.0914 (Jul 22, 2026)
52-week high$0.1415
52-week low$0.0914
Median price$0.1443
Average price$0.1473
Largest weekly change-44.0% (Nov 23, 2022)
Weeks tracked245
Tracking sinceDec 15, 2021

Price History

1W

+2.4%

1M

+2.4%

3M

-15.9%

6M

-21.8%

1Y

-33.9%

3Y

-52.3%

5Y

N/A

All

-61.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.0936 per EA (NDC 70010014701), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 61.1%. It has been tracked across 245 weekly CMS publications since Dec 15, 2021.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?

Since Dec 15, 2021, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.0914 (Jul 22, 2026) to a high of $0.2404 (Dec 15, 2021), with a median of $0.1443 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 8 MEQ CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?

POTASSIUM CL ER 8 MEQ CAPSULE (NDC 70010014701) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.